-
Novartis continues to ‘reimagine’ itself, as Alcon spin-off completed
pharmatimes
April 11, 2019
Novartis has announced the completion of its Alcon eye care spin-off.
-
Alcon to build digital platform to improve cataract surgery
pharmaphorum
December 21, 2018
Novartis’ ophthalmology division Alcon has announced plans to build a digital platform to streamline, simplify and improve cataract surgery for surgeons and patients.
-
Alcon Announces Acquisition of Tear Film Innovations
americanpharmaceuticalreview
December 20, 2018
Alcon has acquired Tear Film Innovations, a privately-held company and manufacturer of the iLux Device, a therapeutic device used to treat Meibomian Gland Dysfunction, a leading cause of dry eye.....
-
Alcon held its first Capital Markets Day for investors and analysts
worldpharmanews
November 28, 2018
Alcon will today hold its first Capital Markets Day for investors and analysts in relation to the previously-announced intention of Novartis to execute a tax-neutral, 100% spinoff of the Alcon business.
-
Novartis files for Alcon spinoff, citing aging population and developing countries as top growth prospects
fiercepharma
November 15, 2018
When Novartis said in June that it would spin off its long-struggling eye-care unit, Alcon, CEO Vas Narasimhan declined to estimate what the valuation on such a transaction might be.
-
Novartis' Alcon adds online training portal to supplement in-person eyecare education centers
fiercepharma
September 21, 2018
Virtual school is now in session at Alcon. The eyecare division of Novartis opened the AlconExperienceAcademy.com portal this week, an extension of its real-world Alcon Experience Academy
-
Novartis eyecare unit Alcon to set up new HQ in Geneva, Switzerland
pharmafile
September 13, 2018
Alcon, the eyecare unit of Novartis, is set to move to a new home next year, after its parent company revealed that the Swiss city of Geneva had been chosen as its new headquarters.
-
Alcon Confirms Commitment to Switzerland Ahead of Proposed Spinoff from Novartis
americanpharmaceuticalreview
September 13, 2018
Alcon has announced plans to locate its future global headquarters in the Canton of Geneva, Switzerland, following completion of its proposed spinoff from Novartis.
-
Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis
worldpharmanews
September 12, 2018
Alcon, the global leader in eye care and a division of Novartis, today announced plans to locate its future global headquarters in the Canton of Geneva, Switzerland, following completion of its proposed spinoff from Novartis. Alcon's new global headquarte
-
Novartis announces intention to spin off Alcon
biospectrumasia
July 09, 2018
The planned spinoff would enable Novartis and Alcon to focus fully on their respective growth strategies, said the company in a statement